SOURCE: Sunwin International Neutraceuticals, Inc.

November 16, 2005 16:01 ET

Sunwin International Neutraceuticals Partners With United States Distribution Corp to Enter the U.S. 25 Billion Sweetener Market

FORT LAUDERDALE, FL and QUFU, CHINA -- (MARKET WIRE) -- November 16, 2005 -- Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN), an industry leader in the production and distribution of Chinese herbs, veterinary medicines and low calorie natural sweetener (Stevia) in China, has signed a distribution agreement with United States Distribution Corp ("USDC"). The agreement calls for USDC to distribute Sunwin's low calorie natural sweetener (Stevia) produced by Sunwin. USDC has relationships with 55,000 retail outlets across the U.S., including warehouses, mass retailers, grocery stores, pharmacies, restaurants, hotels, casinos, convention centers, stadium concessions, gas stations, convenience stores, and natural food chain stores. USDC management has successfully built the FDA approved Pharb Hangover Relief Medicine to an estimated $45 million in revenue over a 4 year period.

Mr. Laiwang Zhang, President and Chairman of Sunwin International, commented, "Following a thorough review and interview process, our management team has selected the USDC as our partner to enter the $25 billion sweetener market in the U.S. We expect this relationship will help boost our global Stevia sales to a new level. Our goal is to achieve $10 million in annual sales for Stevia in the U.S."

Mark De Mattei, CEO of the USDC, stated, "Having examined Stevia manufactured by Sunwin, analyzed the global trends, and surveyed the market demand in the U.S., we are very optimistic about the potential market for Sunwin products in the U.S. Currently, there is a growing awareness about the health effects of sugar and synthetic sweetener. Furthermore, initial market reaction has been extremely positive. We see this as a tremendous opportunity to introduce Stevia in the $25 billion sweetener market in the U.S."

Stevia, a 100% natural sweetener, is extracted from the leaves of the Stevia rebaudiana plant, as a food additive which is used in various products such as beverages, foods, confections, and medicinal products in China and Japan. Forms of Stevia are approximately 300 times sweeter than general sucrose, with only 1/300th of the calories. Stevia is often referred to as the third generation of natural low calorie sweetener. The implications of this go far beyond the simple notion of being a weight watcher's dream. When Stevia products are in their pure unadulterated form they do not adversely affect blood glucose levels, which means that diabetics and hypoglycemics can use them as well. However, the glycosides are not the whole story. Studies have found that the leaf contains proteins, fiber, iron, phosphorus, calcium, potassium, sodium, magnesium, zinc, the flavonoid rutin, Vitamin A, Vitamin C and oil which contains 53 other nutritional constituents, making it the quintessential dietary supplement.

About Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, low-calorie natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumer to provide a quality and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit http://www.sunwin.biz

About United States Distribution Corporation

United States Distribution Corporation ("USDC") has over 15 years experience in bringing new and existing products to retailing outlets. The USDC has successfully built the FDA approved Pharb Hangover Relief Medicine to over $45,000,000 in revenue over a 4 year period. The USDC management's expertise and results are built on long-term relationships with buyers, brokers, wholesale distributors and sales representatives within its respective industries. The USDC's direct line to the buyers includes SYSCO, S.E. Rycoff, Smart & Final, Wal-Mart, Target, K-Mart, Walgreens, Albertsons, Kroger, Safeway, Meijers, Food-4-Less, Save Mart, Food Lion, Long's, CVS, Rite-AID, Eckerd, Osco, Savon, Leaders, Beverage's & More, Liquor Barn, Trader Joe's, Mc Donalds, Burger King, Wendy's, Taco Bell, Pappa John's Domino's, Pizza Hut, Hilton, Marriott, Hyatt, Bally's, Circus-Circus, Silvarado, Bellagio, Wynn's, Treasure Island, Kragen, Checkers, Pep Boys, Pilot Travel Center, Bruce's TA, Loves, Chevron, Shell, Conoco, Speedway, Union 76, Mobil, The Pantry, Texaco, AM/PM, Circle K, BP, 7/11, Quik Trip, Valero, GNC, Dollar, Dollar General, 99 cent Only, Dollar Tree, COSTCO, Sam's Club, Wild Oats, Good Earth, New Seasons, Whole Foods, Home Depot, and Lowes.

Safe Harbor Statement

Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

Contact Information